{
  "documentMetadata": {
    "title": "Septic Arthritis in Adults",
    "lastUpdated": "2024-02-29",
    "sourceFile": "Arthritis, Septic, Adult.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Initial empiric therapy, septic arthritis in adults, acute/chronic monoarticular, polyarticular",
        "Start empiric therapy after collection of blood and joint fluid for culture; review Gram stain of joint fluid.",
        "Synovial fluid WBC > 50,000 with poly predominance."
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Three settings:"
        },
        {
          "type": "nestedContent",
          "content": [
            {
              "type": "header",
              "level": 3,
              "text": "Acute monoarticular"
            },
            {
              "type": "list",
              "items": [
                "Review Gram stain-all empirical treatment are guided by Gram stain.",
                "Differentiate between patient's risk for sexually-transmitted diseases (STD).",
                "Differential diagnosis includes gout and chondrocalcinosis (pseudogout) (crystals in joint fluid)."
              ]
            }
          ]
        },
        {
          "type": "header",
          "level": 3,
          "text": "Chronic monoarticular"
        },
        {
          "type": "nestedContent",
          "content": [
            {
              "type": "header",
              "level": 3,
              "text": "Polyarticular: suspect disseminated gonococcal infection:"
            },
            {
              "type": "list",
              "items": [
                "Usually acute onset, Gram stain is typically negative for gonococci.",
                "If patient is sexually active, culture urethra, cervix, anal canal, throat, blood, joint fluid.",
                "If pustular/hemorrhagic skin lesions and tenosynovitis present, suspect N. gonorrhea.",
                "Expanded differential includes gout, pseudogout, reactive arthritis (HLA-B27 positive), Lyme."
              ]
            }
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Acute monoarticular"
        },
        {
          "type": "list",
          "items": [
            "If risk of STD:",
            "N. gonorrhea",
            "Staph. aureus",
            "Streptococcus spp.",
            "Gram-negative bacilli",
            "If no risk of STD:",
            "Staph. aureus",
            "Streptococcus spp.",
            "Gram-negative bacilli"
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Chronic monoarticular"
        },
        {
          "type": "list",
          "items": [
            "Brucella spp.",
            "Nocardia spp.",
            "Mycobacteria",
            "Fungi"
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Polyarticular"
        },
        {
          "type": "list",
          "items": [
            "N. gonorrhea",
            "B. burgdorferi (Lyme disease)",
            "S. aureus",
            "Group A streptococcus, pneumococcus",
            "Acute rheumatic fever",
            "Post-streptococcal arthritis",
            "Reactive arthritis",
            "Viral: Hepatitis B, Rubella vaccine, Parvo B19, Chikungunya (travel history)"
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "paragraph",
      "text": "Treatment: adequate drainage of purulent joint fluid + systemic antimicrobial therapy"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Acute monoarticular"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "appliesTo": {
              "description": "Patient presents with STD risk",
              "criteria": [
                {
                  "parameter": "gramStain",
                  "value": "negative or positive for gram-negative diplococci"
                }
              ]
            },
            "components": [
              {
                "drug": "Ceftriaxone",
                "dose": "1 gm",
                "route": "IV",
                "frequency": "q24h"
              },
              {
                "drug": "Cefotaxime",
                "dose": "2 gm",
                "route": "IV",
                "frequency": "q8h",
                "connector": "or"
              },
              {
                "drug": "Ceftizoxime",
                "dose": "1 gm",
                "route": "IV",
                "frequency": "q8h",
                "connector": "or"
              }
            ],
            "notes": "See comments for treatment of concomitant chlamydial infection."
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "appliesTo": {
              "description": "Patient presents with STD risk",
              "criteria": [
                {
                  "parameter": "gramStain",
                  "value": "positive for gram-positive cocci"
                }
              ]
            },
            "components": [
              {
                "drug": "Vancomycin",
                "dose": "15-20 mg/kg",
                "route": "IV",
                "frequency": "q8-12h"
              }
            ],
            "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 15-20 µg/mL)"
          }
        },
        {
          "type": "crossReference",
          "referenceData": {
            "text": "Gram stain positive for gram-negative bacilli: See Arthritis Gram-Negative Bacilli",
            "targetType": "internalDocument",
            "targetIdentifier": "Arthritis Gram-Negative Bacilli"
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "appliesTo": {
              "description": "No or low STD risk",
              "criteria": [
                {
                  "parameter": "gramStain",
                  "value": "negative"
                }
              ]
            },
            "components": [
              {
                "drug": "Vancomycin",
                "dose": "15-20 mg/kg",
                "route": "IV",
                "frequency": "q8-12h"
              },
              {
                "drug": "Ceftriaxone",
                "dose": "1 gm",
                "route": "IV",
                "frequency": "q24h",
                "connector": "+"
              }
            ],
            "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 15-20 µg/mL)"
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "appliesTo": {
              "description": "No or low STD risk",
              "criteria": [
                {
                  "parameter": "gramStain",
                  "value": "negative"
                }
              ]
            },
            "components": [
              {
                "drug": "Vancomycin"
              },
              {
                "drug": "Cefepime",
                "dose": "2 gm",
                "route": "IV",
                "frequency": "q8h",
                "connector": "+"
              }
            ],
            "notes": "preferred for possible healthcare-associated infection"
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "appliesTo": {
              "description": "No or low STD risk",
              "criteria": [
                {
                  "parameter": "gramStain",
                  "value": "positive for gram-positive cocci"
                }
              ]
            },
            "components": [
              {
                "drug": "Vancomycin"
              }
            ]
          }
        },
        {
          "type": "crossReference",
          "referenceData": {
            "text": "Gram-stain positive for Gram-negative bacilli: See Arthritis Gram-Negative Bacilli",
            "targetType": "internalDocument",
            "targetIdentifier": "Arthritis Gram-Negative Bacilli"
          }
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Chronic monoarticular"
        },
        {
          "type": "paragraph",
          "text": "Empiric therapy not generally recommended, treat for specific etiology"
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Polyarticular"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "components": [
              {
                "drug": "Vancomycin",
                "dose": "15-20 mg/kg",
                "route": "IV",
                "frequency": "q8-12h"
              },
              {
                "drug": "Ceftriaxone",
                "dose": "1 gm",
                "route": "IV",
                "frequency": "q24h",
                "connector": "+"
              }
            ],
            "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 15-20 µg/mL)"
          }
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Acute monoarticular"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "appliesTo": {
              "description": "No STD risk"
            },
            "components": [
              {
                "drug": "Vancomycin",
                "dose": "15-20 mg/kg",
                "route": "IV",
                "frequency": "q8-12h"
              },
              {
                "drug": "Ciprofloxacin",
                "dose": "400 mg",
                "route": "IV",
                "frequency": "q12h",
                "connector": "+"
              },
              {
                "drug": "Levofloxacin",
                "dose": "750 mg",
                "route": "IV",
                "frequency": "q24h",
                "connector": "or"
              }
            ],
            "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 15-20 µg/mL)"
          }
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Duration of therapy not well studied. One randomized controlled trial of septic arthritis in adults caused by a variety of pathogens found that two weeks of oral therapy was non-inferior to four weeks of oral therapy following surgical drainage and a median of 1-2 days of intravenous therapy; 99 of the 154 patients has arthritis of the hand or wrist (Ann Rheum Dis. 2019; 78:1114-1121)."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Approximately 20% of patients with septic arthritis presentation have negative cultures; a proportion of these go on to develop rheumatic diseases (Joint Bone Spine 79:156, 2012)",
        "For patients with STD risk, Azithromycin 1 gm po or Doxycycline 100 mg po twice daily for 7 days is for treatment of concomitant chlamydial infection",
        "See also, Disseminated Gonorrhea.",
        "If polyarticular arthritis, consider Lyme disease if exposure areas known to harbor infected ticks; typically involves large joints.",
        "Specific therapy for S. aureus septic arthritis.",
        "Reference: Curr Rheumatol Rep 15:332, 2013."
      ]
    }
  ]
}
